🔎 Trials Near Me

Gara Jalqabaatti › Myeloma Baay’ee › Maryland › Baltimore

Qorannoo klinikaalii Myeloma Baay’ee Baltimore, MD keessatti

Qorannoo 13 Myeloma Baay’ee f Baltimore fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Namoota walitti qabaa jiraSadarkaa jalqabaa 1
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06398457

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 3
  • University of Maryland School of Medicine, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07258511

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 3
  • Johns Hopkins Hospital, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07518186

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 3
  • Johns Hopkins University School of Medicine JHUSOM, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05552222

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Namoota walitti qabaa jiraSadarkaa 3
  • Johns Hopkins Asthma & Allergy Center, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07648264

Collection of Tissue Samples for Cancer Research

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Johns Hopkins University, Baltimore
2 Months · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT00900198

A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 3
  • University of Maryland | Greenebaum Cancer Center, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06980480

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT07764978

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

Namoota walitti qabaa jiraSadarkaa 1
  • University of Maryland Greenbaum Comprehensive Cancer Center, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT07280013

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Namoota walitti qabaa jiraSadarkaa 3
  • Greater Baltimore Medical Center, Baltimore
Umuriin hundi · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT05561387

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

Namoota walitti qabaa jiraSadarkaa 3
  • Greenebaum Cancer Center UM of MD, Baltimore
  • John Hopkins, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT05243797

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Sibley Memorial Hospital, Baltimore
  • University of Maryland, Baltimore
  • Johns Hopkins Main Center, Baltimore
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 24-Bit-2026 · NCT04988555

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 1/2
  • Johns Hopkins Medicine - The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Ful-2025 · NCT05372354

Qorannoo Myeloma Baay’ee magaalota biroo keessatti

Qorannoo biroo Baltimore keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.